[{"symbol": "GERM", "assetClass": "Equity", "aum": 9677358, "avgVolume": 1202, "cusip": "032108581", "description": "The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.", "domicile": "US", "etfCompany": "Amplify", "expenseRatio": 0.68, "inceptionDate": "2020-06-18", "isin": "US0321085815", "name": "ETFMG Treatments, Testing and Advancements ETF", "nav": 19.34, "navCurrency": "USD", "sectorsList": [{"industry": "Basic Materials", "exposure": 0}, {"industry": "Communication Services", "exposure": 0}, {"industry": "Consumer Cyclical", "exposure": 0}, {"industry": "Consumer Defensive", "exposure": 0}, {"industry": "Energy", "exposure": 0}, {"industry": "Financial Services", "exposure": 0}, {"industry": "Healthcare", "exposure": 100}, {"industry": "Industrials", "exposure": 0}, {"industry": "Real Estate", "exposure": 0}, {"industry": "Technology", "exposure": 0}, {"industry": "Utilities", "exposure": 0}], "website": "", "holdingsCount": 57}]